Cancer Patients, Oncologists Have Discordant Opinions on Prognosis

This article originally appeared here.
Share this content:
Cancer Patients, Oncologists Have Discordant Opinions on Prognosis
Cancer Patients, Oncologists Have Discordant Opinions on Prognosis

FRIDAY, July 15, 2016 (HealthDay News) -- Cancer patients and their oncologists often hold different opinions about the patient's chances for survival and how long they might live, according to a study published online July 14 in JAMA Oncology.

Researchers asked 236 patients with advanced cancer about their prognosis. The 38 oncologists who treated them independently said they would "not have been surprised" if their patients died within a year. The team also asked whether patients knew that their opinions about their prognosis differed from those of their oncologists and the extent to which life expectancy influenced treatment options.

The researchers found that 68 percent of patients rated their odds for survival differently from their oncologists. Almost all patients were more optimistic than their oncologist. Of the 68 percent, only 10 percent understood that their views and their oncologist's differed. Seven out of 10 patients surveyed said they would opt for supportive care rather than aggressive treatment as the end of their lives neared. To make an informed decision, however, patients need to know when death is imminent, the researchers said.

"Our findings suggest that patient-oncologist prognostic discordance is common in advanced cancer and that it is usually due to patients not knowing their oncologists' prognosis opinions," the authors write. "This study supports the urgent clinical and societal need to better understand what it means to communicate well about prognosis to achieve treatment that honors patients' values, preferences, and wishes."

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Risk for Interval CRC Higher in Blacks Than Whites

Risk for Interval CRC Higher in Blacks Than ...

Differences most pronounced for cancer of the distal colon and the rectum

Even Small Amounts of Alcohol Can Affect Breast Cancer Risk

Even Small Amounts of Alcohol Can Affect Breast ...

Small glass of wine each day can up odds of both premenopausal and postmenopausal breast cancer

ATS: Angiotensin II Improves BP in Vasodilatory Shock

ATS: Angiotensin II Improves BP in Vasodilatory Shock

Angiotensin II effective for vasodilatory shock in patients not responding to conventional vasopressors

is free, fast, and customized just for you!

Already a member?

Sign In Now »